How diabetes drug metformin inhibits progression of pancreatic cancer

Investigators may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer. In their report, the research team describes finding that metformin decreases the inflammation and fibrosis characteristic of the most common form of pancreatic cancer.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1RsFyV8